Novel HIV-1 Integrase Inhibitor Development by Virtual Screening Based on QSAR Models

E-ISSN： 1873-4294|16|4|441-448

ISSN： 1568-0266

Source： Current Topics in Medicinal Chemistry, Vol.16, Iss.4, 2016-02, pp. : 441-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel integrase inhibitor promising in triple-class resistant HIV-1

Inpharma, Vol. 1, Iss. 1560, 2006-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Raltegravir: an integrase inhibitor for HIV-1

By Evering Teresa H Markowitz Martin

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 3, 2008-03 ,pp. : 413-422

Informa Healthcare

Access to resources Recommend Favorite

Structure-based HIV-1 integrase inhibitor design: a future perspective

By Neamati N.

Expert Opinion on Investigational Drugs, Vol. 10, Iss. 2, 2001-02 ,pp. : 281-296

Informa Healthcare

Access to resources Recommend Favorite

Structure-Based Inhibitor Design Targeting HIV-1 Integrase

Current Drug Targets - Infectious Disorders, Vol. 2, Iss. 3, 2002-09 ,pp. : 217-234

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Study on Diketo Acid and Carboxamide Derivatives as Potent HIV- 1 Integrase Inhibitor

Letters in Drug Design & Discovery, Vol. 11, Iss. 5, 2014-06 ,pp. : 618-627

Bentham Science Publishers

Access to resources Recommend Favorite